Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: July 31, 2015
Data suggest that several years of systemic hormone therapy are safe in mutation carriers who have intact breasts and no personal history of breast...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: July 23, 2015
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: June 25, 2015
Yes. Oophorectomy is associated with a reduction in mortality in women with a BRCA1 mutation who have breast cancer, according to this retrospecti...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: June 24, 2015
Women with atypical hyperplasia are at increased risk for breast cancer. We need to characterize that risk for patients and ensure appropriat...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: May 29, 2015
The latest guidance on safe use of menopausal hormone therapy
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: April 9, 2015
A 25-year-old patient presents with pelvic pain and dyspareunia. A 19-year-old patient with a history of ovarian cystectomy for dermoid cyst report...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: March 31, 2015
Yes. Women with first-degree relatives with breast and prostate cancer had a 78% elevated risk for developing breast cancer (adjusted hazard ratio...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: March 13, 2015
A large Danish cohort study clarifies the risk factors for depression after a diagnosis of breast cancer, which include advanced age, comorbidities...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: February 28, 2015
Myriad sonographic features characterize cystic adnexal pathology. Here, three cases of benign, resolving cysts, including when to follow-up.
Audio
- Author:
- Andrew M. Kaunitz, MD
Publish date: February 25, 2015
Prescribing systemic hormone therapy is common, but controversial. Dr. Kaunitz elaborates on specific dosing and tapering patients, as well as cons...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: December 30, 2014
New guidance has focused on cervical cytology screening intervals and the role of human papillomavirus (HPV) testing—but has not addressed o...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: December 17, 2014
The following images demonstrate the ability of 3D sonography to identify the unicornuate, bicornuate, didelphic, and DES-exposed uterus
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: November 5, 2014
Accurate diagnosis of such anomalies has prognostic importance for both obstetric and gynecologic outcomes
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: October 10, 2014
About 20% useful to identify otherwise undetected CIN2 or worse or CIN 3 or worse. The absolute risks of disease associated with the random biopsy...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: July 30, 2014
ObGyns—many of whom have access only to 2D ultrasound—are increasingly called upon to determine the positioning, or malpositioning, of ...
